bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
090-71-4002

Order Name:
PGX for UGT1A1 (UGT A1 Polymorphism) **

 
Useful For:

Identifying individuals who are at increased risk of adverse drug reactions with drugs that are metabolized by UGT1A1; especially irinotecan, but also including atazanavir, nilotinib, pazopanib, and belinostat

 
Methodology:
Polymerase chain reaction
 
AliasesName:
Pharmacogenetic for UGT1A1
 
 
 
Test Code:
090-71-4002

Order Name:
PGX for UGT1A1 (UGT A1 Polymorphism) **

 
Patient Preparation:
N/A
 
Collection Specimen Or Container:
Blood/ K3 EDTA (Lavender Top) 3 mL, 2 tubes
 
Specimen Testing Type:
Whole Blood EDTA, minimum volume 3 mL
 
Sub Mission Container:
Original tube
 
Rejection Criteria:
Hemolysis: Hemolysis interfere
Other: Over Stability / Frozen specimen will be reject.
 
Specimen Stabillity:
Specimen Type Temperature Time
Whole blood, EDTA Ambient  Same day
Refrigerated, 2oC to 8oC 7 days
 
 
 
Test Code:
090-71-4002

Order Name:
PGX for UGT1A1 (UGT A1 Polymorphism) **

 
Method detail:
Polymerase chain reaction
 
Schedule:
N/A **Sent Out to Ramathibodi
 
Turnaround Time:
Received specimen to report within 3-5 days
(exception for official holidays)
 
Performing Location:
Ramathibodi
Referral Lab Services, Laboratory Department 14160-2
 
 
 
Test Code:
090-71-4002

Order Name:
PGX for UGT1A1 (UGT A1 Polymorphism) **

 
 
Clinical Reference:
  1. Ramathibodi Laboratory Guide book 2560-2562
  2. www.mayocliniclabs.com (Retrieved: 7 Jul 2020)